CD8A and neoplasm: Tumor immune cell profiling in Bmal1ΔDC mice confirmed a blunted cytotoxic CD8+ T-cell response, with fewer IFN-γ+ and Granzyme B+ CD8+ T cells after ICT (Fig. 4D).